VAERS reports by lot

GSK Varicella/Shingles lot 92C34: VAERS reports

25 VAERS reports list lot 92C34 as a GSK Varicella/Shingles vaccine, received between 2020-10-30 and 2022-09-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2526%
Injection-site / Local reaction2526%
Neurological99%
Cardiac / Cardiovascular99%
Dermatological (non-injection-site)88%
Musculoskeletal77%
Gastrointestinal55%
Allergic / Anaphylactic44%
Respiratory22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
Michigan3
Missouri2
Pennsylvania2
California1
North Carolina1
Washington1
Oregon1
Utah1
Florida1
Ohio1
Georgia1

Reports by month received

2020-101
2020-116
2020-123
2021-013
2021-021
2021-032
2021-041
2021-061
2021-091
2021-102
2021-121
2022-031
2022-041
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.